These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 19459152

  • 1. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
    Teixeira L, Sousa DM, Nunes AF, Sousa MM, Herzog H, Lamghari M.
    J Cell Biochem; 2009 Aug 01; 107(5):908-16. PubMed ID: 19459152
    [Abstract] [Full Text] [Related]

  • 2. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
    Lee NJ, Doyle KL, Sainsbury A, Enriquez RF, Hort YJ, Riepler SJ, Baldock PA, Herzog H.
    J Bone Miner Res; 2010 Aug 01; 25(8):1736-47. PubMed ID: 20200977
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM.
    J Bone Miner Res; 2005 Oct 01; 20(10):1851-7. PubMed ID: 16160743
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M, Stanojević S, Vujić V, Beck-Sickinger A, von Hörsten S.
    Regul Pept; 2005 Jan 15; 124(1-3):163-72. PubMed ID: 15544855
    [Abstract] [Full Text] [Related]

  • 5. NPY regulation of bone remodelling.
    Lee NJ, Herzog H.
    Neuropeptides; 2009 Dec 15; 43(6):457-63. PubMed ID: 19748118
    [Abstract] [Full Text] [Related]

  • 6. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z.
    Can J Physiol Pharmacol; 2003 Feb 15; 81(2):177-85. PubMed ID: 12710532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y and osteoblast differentiation--the balance between the neuro-osteogenic network and local control.
    Franquinho F, Liz MA, Nunes AF, Neto E, Lamghari M, Sousa MM.
    FEBS J; 2010 Sep 15; 277(18):3664-74. PubMed ID: 20681986
    [Abstract] [Full Text] [Related]

  • 12. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S, Boey D, Herzog H.
    Neuropeptides; 2004 Aug 15; 38(4):189-200. PubMed ID: 15337371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N, Lou W, Lee SO, Mehraein-Ghomi F, Kirk JS, Conroy JM, Zhang H, Gao AC.
    Clin Cancer Res; 2006 Mar 01; 12(5):1420-30. PubMed ID: 16533764
    [Abstract] [Full Text] [Related]

  • 15. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M, Ghibaudi L, Gao J, Hwa JJ.
    Obes Res; 2005 Jan 01; 13(1):36-47. PubMed ID: 15761161
    [Abstract] [Full Text] [Related]

  • 16. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ, Young D, Baer K, Herzog H, During MJ.
    Epilepsia; 2006 Apr 01; 47(4):773-80. PubMed ID: 16650144
    [Abstract] [Full Text] [Related]

  • 17. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N.
    Bone; 2008 Mar 01; 42(3):535-46. PubMed ID: 18166509
    [Abstract] [Full Text] [Related]

  • 18. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL, Zheng F, Qiu MC.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1992-6. PubMed ID: 19062743
    [Abstract] [Full Text] [Related]

  • 19. Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors.
    Kempná P, Körner M, Waser B, Hofer G, Nuoffer JM, Reubi JC, Flück CE.
    Mol Cell Endocrinol; 2010 Jan 15; 314(1):101-9. PubMed ID: 19699258
    [Abstract] [Full Text] [Related]

  • 20. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A, Schulz H, Emons G, Gründker C.
    Gynecol Endocrinol; 2008 Jun 15; 24(6):331-8. PubMed ID: 18584413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.